Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
Glioblastoma (GBM) is the most common and aggressive type of tumour arising from the central nervous system. GBM remains an incurable disease despite advancement in therapies, with overall survival of approximately 15 months. Recent literature has highlighted that GBM releases tumoural content which...
Main Authors: | Juliana Müller Bark, Arutha Kulasinghe, Gunter Hartel, Paul Leo, Majid Ebrahimi Warkiani, Rosalind L. Jeffree, Benjamin Chua, Bryan W. Day, Chamindie Punyadeera |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.681130/full |
Similar Items
-
The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
by: Arutha Kulasinghe, et al.
Published: (2018-08-01) -
Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
by: Arutha Kulasinghe, et al.
Published: (2019-01-01) -
Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
by: Arutha Kulasinghe, et al.
Published: (2019-03-01) -
The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells
by: Arutha Kulasinghe, et al.
Published: (2020-06-01) -
PD-L1 expressing circulating tumour cells in head and neck cancers
by: Arutha Kulasinghe, et al.
Published: (2017-05-01)